FDA Inspection 1259818 — Zhejiang Huahai Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical Co., Ltd. on January 24, 2025 in Linhai. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- January 24, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linhai (China)